Mark C. Griffiths has been named chief executive officer of Carbogen Amcis AG, a pharmaceutical process development and API manufacturer. Mr. Griffiths will have responsibility for Carbogen Amcis’ Swiss business and will report to Jay Vyas, managing director of parent company Dishman Pharmaceuticals and Chemicals Ltd.
 
Mr. Griffiths has worked at Carbogen Amcis for almost 10 years. Most recently, he has been working for the Dishman Group as operations advisor overseeing the design and construction of the group’s large-scale manufacturing facilities for commercial supply of Highly Potent APIs (HPAPIs) in Shanghai, China, and Ahmedabad, India.
 
“We are delighted that Mark agreed to join Carbogen Amcis as chief executive officer,” commented Mr. Vyas. “Mark’s industrial expertise and proven track record in the pharmaceutical industry make him the ideal executive to lead Carbogen Amcis’ growth. We are confident in Marks’ ability to accelerate the success of our company and our customers by maintaining the focus on high performance.”
 
Griffiths has more than 28 years of pharmaceutical and fine chemical industry operational experience. He has designed, built and managed facilities ranging in function from research and development to manufacturing.